Photobiostimulation Market Size (2024 - 2029)

The photobiostimulation market is projected to experience significant growth due to the increasing prevalence of chronic diseases and advancements in technology. The market's expansion is driven by the rising demand for photobiostimulation therapies, particularly for conditions such as diabetes-related wound healing and chronic pain disorders like arthritis and osteoporosis. Technological innovations and new product launches are further contributing to the market's development. However, the growth may be challenged by the availability of alternative treatment options.

INSTANT ACCESS

Market Size of Photobiostimulation Industry

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:
Photobiostimulation Market Summary
Study Period 2021 - 2029
Market Size (2024) USD 240.80 Million
Market Size (2029) USD 393.40 Million
CAGR (2024 - 2029) 10.31 %
Fastest Growing Market Asia Pacific
Largest Market North America

Major Players

Photobiostimulation Market Major Players

*Disclaimer: Major Players sorted in no particular order

Need a report that reflects how COVID-19 has impacted this market and its growth?

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Photobiostimulation Market Analysis

The Photobiostimulation Market size is estimated at USD 240.80 million in 2024, and is expected to reach USD 393.40 million by 2029, growing at a CAGR of 10.31% during the forecast period (2024-2029).

The significant factor attributing to the market growth is the growing incidence of chronic diseases, leading to an increase in the number of patients being treated using methods of photobiostimulation. Additional factors, such as the rising prevalence of chronic pain disorders such as arthritis, osteoporosis, and the increasing geriatric population, will drive the market for photobiostimulation during the forecast period. For instance, according to a report published by the Osteoarthritis Action Alliance in January 2024, it is estimated that 1 in 5 United States adults have some form of arthritis, and osteoarthritis (OA) is the most common form of arthritis, affecting 32.5 million United States adults. Hence, the high prevalence of osteoarthritis in the United States is expected to drive the demand for photobiostimulation therapy in the forecasted period in the region.

Photobiostimulation therapy has also been utilized in diabetic wound healing treatment. A photobiomodulation response is produced when cells are exposed to radiation, which changes cellular functions and promotes the healing of diabetic wounds. By modifying many cellular and molecular processes, photobiomodulation therapy (PBMT) employing red and near-infrared (NIR) wavelengths is considered a promising treatment for accelerating the rate of diabetic wound healing, eliminating pain, and reducing inflammation. According to a report published by the International Diabetic Federation (IDF) in 2022, 537 million people have diabetes worldwide in 2021, and more than 51 million people will be in the North American region; by 2045, it will rise to 63 million. The diabetic population is high in the United States, which ultimately results in a higher number of diabetic foot ulcers. This is likely to increase the demand for photobiostimulation therapy as a cure, and it is expected to grow in the market over the forecast period.

Advancements in technology and new product launches by the market players focusing on photobiostimulation therapy are also aiding the growth of the studied market over the forecast period. For instance, in June 2023, Lumaflex, a health tech company, launched its new Lumaflex Body Pro. This revolutionary red light therapy device is currently in production and has achieved FDA Class 2 Certification. It has become a popular treatment for muscle recovery among fitness communities such as bodybuilders and mixed martial arts (MMA) athletes.

Moreover, in February 2024, BIOPTRON AG presented positive clinical data on using photobiostimulation treatment devices for wound healing at the Dubai World Dermatology Congress. The study discovered that the therapy dramatically decreased healing time while improving patient outcomes. Therefore, rising clinical trials and company activities are likely to add to the market growth.

Thus, the growing incidence of chronic diseases like diabetes and technological advancements accompanied by new products launched are expected to propel the growth of the photobiostimulation market. However, the rising availability of alternative treatments will hinder the market's growth over the forecast period.

Photobiostimulation Industry Segmentation

As per the scope of this report, photobiostimulants are being used to minimize tissue damage and reduce swelling, pain, and edema to treat deeper skin wounds and nerves. The photobiostimulation market is segmented by Technique, Wavelength Type, End-User, and Geography. The technique segment is further segmented into Wound Care, Pain Management, Cosmetic Application, and Other Techniques. The wavelength is further separated into Infrared Light, Red Light, and Other Wavelength Types. The End User Segment is further divided into Specialty Clinics, Research Institutes, and Other End Users. The geography region is segregated into North America, Europe, Asia-Pacific, Middle East and Africa, and South America. The report also covers the estimated market sizes and trends of 17 countries across major regions globally. The report offers the value in USD for the above segments.

By Application
Wound Care
Pain Management
Cosmetic Application
Other Applications
By Wavelength Type
Infrared Light
Red Light
Other Wavelength Types
By End-User
Specialty Clinics
Research Institutes
Other End-Users
Geography
North America
United States
Canada
Mexico
Europe
Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific
China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle East and Africa
GCC
South Africa
Rest of Middle East and Africa
South America
Brazil
Argentina
Rest of South America
Need A Different Region Or Segment?
Customize Now

Photobiostimulation Market Size Summary

The photobiostimulation market is poised for significant growth, driven by the increasing incidence of chronic diseases and the rising geriatric population. This market is characterized by the application of photobiostimulation therapy in treating conditions such as arthritis, osteoporosis, and diabetic wound healing. The therapy utilizes red and near-infrared wavelengths to promote cellular functions, aiding in pain reduction, inflammation control, and tissue repair. Technological advancements and new product launches, such as Lumaflex's FDA-certified red light therapy device, are further propelling market expansion. The therapy's effectiveness in managing chronic pain and accelerating wound healing is gaining traction, particularly in regions with high diabetes prevalence, like the United States.

North America is expected to witness substantial market growth due to its advanced healthcare infrastructure and the increasing demand for non-invasive treatments. The region's aging demographic and the rising prevalence of sports-related injuries are driving the adoption of photobiostimulation therapies. The market is consolidated, with major players like BioLight Technologies LLC and Erchonia Corporation leading through strategic acquisitions and product innovations. The growing preference for minimally invasive surgeries and significant investments in research and development are also contributing to the market's expansion. Despite the promising growth prospects, the availability of alternative treatments poses a challenge to the market's trajectory.

Explore More

Photobiostimulation Market Size - Table of Contents

  1. 1. MARKET DYNAMICS

    1. 1.1 Market Overview

    2. 1.2 Market Drivers

      1. 1.2.1 Rising Incidence of Osteoporosis and Arthritis

      2. 1.2.2 Rising Demand for Non-Invasive Treatments

    3. 1.3 Market Restraints

      1. 1.3.1 Availability of Alternative Treatments

    4. 1.4 Porter's Five Forces Analysis

      1. 1.4.1 Bargaining Power of Buyers/Consumers

      2. 1.4.2 Bargaining Power of Suppliers

      3. 1.4.3 Threat of New Entrants

      4. 1.4.4 Threat of Substitute Products

      5. 1.4.5 Intensity of Competitive Rivalry

  2. 2. MARKET SEGMENTATION (Market Size by Value - USD)

    1. 2.1 By Application

      1. 2.1.1 Wound Care

      2. 2.1.2 Pain Management

      3. 2.1.3 Cosmetic Application

      4. 2.1.4 Other Applications

    2. 2.2 By Wavelength Type

      1. 2.2.1 Infrared Light

      2. 2.2.2 Red Light

      3. 2.2.3 Other Wavelength Types

    3. 2.3 By End-User

      1. 2.3.1 Specialty Clinics

      2. 2.3.2 Research Institutes

      3. 2.3.3 Other End-Users

    4. 2.4 Geography

      1. 2.4.1 North America

        1. 2.4.1.1 United States

        2. 2.4.1.2 Canada

        3. 2.4.1.3 Mexico

      2. 2.4.2 Europe

        1. 2.4.2.1 Germany

        2. 2.4.2.2 United Kingdom

        3. 2.4.2.3 France

        4. 2.4.2.4 Italy

        5. 2.4.2.5 Spain

        6. 2.4.2.6 Rest of Europe

      3. 2.4.3 Asia-Pacific

        1. 2.4.3.1 China

        2. 2.4.3.2 Japan

        3. 2.4.3.3 India

        4. 2.4.3.4 Australia

        5. 2.4.3.5 South Korea

        6. 2.4.3.6 Rest of Asia-Pacific

      4. 2.4.4 Middle East and Africa

        1. 2.4.4.1 GCC

        2. 2.4.4.2 South Africa

        3. 2.4.4.3 Rest of Middle East and Africa

      5. 2.4.5 South America

        1. 2.4.5.1 Brazil

        2. 2.4.5.2 Argentina

        3. 2.4.5.3 Rest of South America

Photobiostimulation Market Size FAQs

The Photobiostimulation Market size is expected to reach USD 240.80 million in 2024 and grow at a CAGR of 10.31% to reach USD 393.40 million by 2029.

In 2024, the Photobiostimulation Market size is expected to reach USD 240.80 million.

Photobiostimulation Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)